FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Volker Höllt

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Procedures

Immunohistochemistry

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Axel Becker; Gerd Geisslinger; Gisela Grecksch; Volker Höllt; Radovan Murín; Andreas Zimmer; Helmut Schröder
Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
Christine Börner; Volker Höllt; Jürgen Kraus
Mechanisms of the inhibition of nuclear factor-κB by morphine in neuronal cells.
Christine Börner; Volker Höllt; Elisa Martella; Jürgen Kraus
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Volker Höllt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Axel Becker; Gerd Geisslinger; Gisela Grecksch; Volker Höllt; Radovan Murín; Andreas Zimmer; Helmut Schröder
Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
Naunyn-Schmiedeberg's archives of pharmacology 2013;386(5):369-82.
2012: Christine Börner; Volker Höllt; Jürgen Kraus
Mechanisms of the inhibition of nuclear factor-κB by morphine in neuronal cells.
Molecular pharmacology 2012;81(4):587-97.
2012: Christine Börner; Volker Höllt; Elisa Martella; Jürgen Kraus
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.
Neuroimmunomodulation 2012;19(3):180-6.
2011: Gisela Grecksch; Volker Höllt; Anne-Katja Imhof; Sascha Just; Thomas Koch; Amelie Lupp; Claudia Pierstorff; Axel Becker; Christian Doll; Laura Glück; Ralf Stumm; Stefan Schulz
Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(39):13890-6.
2011: Christian Doll; Volker Höllt; Thomas Koch; Jens Konietzko; Florian Pöll; Stefan Schulz
Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.
British journal of pharmacology 2011;164(2):298-307.
2011: Helmut Schröder; Volker Höllt; Axel Becker
Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue.
Neurochemistry international 2011;58(1):9-13.
2010: Jürgen Kraus; Lienhard Lehmann; Christine Börner; Volker Höllt
Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4.
Molecular immunology 2010;48(1-3):257-63.
2010: Liquan Yang; Anja Seifert; Daifei Wu; Xiaoqian Wang; Vladan Rankovic; Helmut Schröder; Lars-Ove Brandenburg; Volker Höllt; Thomas Koch
Role of phospholipase D2/phosphatidic acid signal transduction in micro- and delta-opioid receptor endocytosis.
Molecular pharmacology 2010;78(1):105-13.
2010: Monika Riek-Burchardt; Angela Kolodziej; Petra Henrich-Noack; Klaus G Reymann; Volker Höllt; Ralf Stumm
Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia.
Neuropharmacology 2010;58(1):199-207.
2009: Christine Börner; Michal Smida; Volker Höllt; Burkhart Schraven; Jürgen Kraus
Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
The Journal of biological chemistry 2009;284(51):35450-60.
2009: Marija Rankovic; Lea Jacob; Vladan Rankovic; Lars-Ove Brandenburg; Helmut Schröder; Volker Höllt; Thomas Koch
ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2.
Cellular signalling 2009;21(12):1784-93.
2009: Gisela Grecksch; Heinz Rüthrich; Volker Höllt; Axel Becker
Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats.
Psychoneuroendocrinology 2009;34 Suppl 1():S258-64.
2009: Thomas Koch; Anja Seifert; Dai-Fei Wu; Marija Rankovic; Jürgen Kraus; Christine Börner; Lars-Ove Brandenburg; Helmut Schröder; Volker Höllt
mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.
Journal of neurochemistry 2009;110(4):1288-96.
2009: Christine Börner; Beate Warnick; Michal Smida; Roland Hartig; Jonathan A Lindquist; Burkhart Schraven; Volker Höllt; Jürgen Kraus
Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(2):882-9.
2009: Helmut Schröder; Dai-Fei Wu; A Seifert; M Rankovic; Stefan Schulz; Volker Höllt; Thomas Koch
Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor.
Neuropharmacology 2009;56(4):768-78.
2008: Susanne Ammon-Treiber; Gisela Grecksch; Charalampos Angelidis; Patra Vezyraki; Volker Höllt; Axel Becker
Emotional and learning behaviour in mice overexpressing heat shock protein 70.
Neurobiology of learning and memory 2008;90(2):358-64.
2008: Christine Börner; Jürgen Kraus; Andrea Bedini; Burkhart Schraven; Volker Höllt
T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.
Molecular pharmacology 2008;74(2):496-504.
2008: Ying-Jian Liang; Dai-Fei Wu; Ralf Stumm; Volker Höllt; Thomas Koch
Membrane glycoprotein M6A promotes mu-opioid receptor endocytosis and facilitates receptor sorting into the recycling pathway.
Cell research 2008;18(7):768-79.
2008: Angela Kolodziej; Stefan Schulz; Alice Guyon; Dai-Fei Wu; Manuela Pfeiffer; Veysel Odemis; Volker Höllt; Ralf Stumm
Tonic activation of CXC chemokine receptor 4 in immature granule cells supports neurogenesis in the adult dentate gyrus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(17):4488-500.
2008: Angela Kolodziej; Ralf Stumm; Axel Becker; Volker Höllt
Endogenous opioids inhibit ischemia-induced generation of immature hippocampal neurons via the mu-opioid receptor.
The European journal of neuroscience 2008;27(6):1311-9.
2008: Christine Börner; Andrea Bedini; Volker Höllt; Jürgen Kraus
Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes.
Molecular pharmacology 2008;73(3):1013-9.
2008: Thomas Koch; Volker Höllt
Role of receptor internalization in opioid tolerance and dependence.
Pharmacology & therapeutics 2008;117(2):199-206.
2008: Dai-Fei Wu; Li-Quan Yang; Andrea Goschke; Ralf Stumm; Lars-Ove Brandenburg; Ying-Jian Liang; Volker Höllt; Thomas Koch
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors.
Journal of neurochemistry 2008;104(4):1132-43.
2007: Susanne Ammon-Treiber; Daniela Stolze; Volker Höllt
Differential effects of mu-opioid receptor agonists in a hippocampal hypoxia/hypoglycemia model.
Brain research 2007;1183():60-5.
2007: Ralf Stumm; Angela Kolodziej; Vincent Prinz; Matthias Endres; Dai-Fei Wu; Volker Höllt
Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
Journal of neurochemistry 2007;103(4):1666-81.
2007: Christine Börner; Ralf Stumm; Volker Höllt; Jürgen Kraus
Comparative analysis of mu-opioid receptor expression in immune and neuronal cells.
Journal of neuroimmunology 2007;188(1-2):56-63.
2007: Dai-Fei Wu; Thomas Koch; Ying-Jian Liang; Ralf Stumm; Stefan Schulz; Helmut Schröder; Volker Höllt
Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling.
The Journal of biological chemistry 2007;282(30):22239-47.
2007: Ralf Stumm; Angela Kolodziej; Stefan Schulz; Jhumku D Kohtz; Volker Höllt
Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon.
The Journal of comparative neurology 2007;502(3):382-99.
2007: Susanne Ammon-Treiber; Gisela Grecksch; Charalampos Angelidis; Patra Vezyraki; Volker Höllt; Axel Becker
Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70.
Naunyn-Schmiedeberg's archives of pharmacology 2007;375(2):115-21.
2007: Ralf Stumm; Volker Höllt
CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain.
Journal of molecular endocrinology 2007;38(3):377-82.
2007: Stefan Schulz; Ralf Stumm; Volker Höllt
Immunofluorescent identification of neuropeptide B-containing nerve fibers and terminals in the rat hypothalamus.
Neuroscience letters 2007;411(1):67-71.
2007: Christine Börner; Volker Höllt; Jürgen Kraus
Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.
Neuroimmunomodulation 2007;14(6):281-6.
2007: Christine Börner; Volker Höllt; Walter Sebald; Jürgen Kraus
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Journal of leukocyte biology 2007;81(1):336-43.
2007: Ying-Jian Liang; Dai-Fei Wu; Li-Quan Yang; Volker Höllt; Thomas Koch
Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling.
Molecular pharmacology 2007;71(1):123-31.
2006: Jürgen Kraus; Christine Börner; Uwe Lendeckel; Volker Höllt
Interferon-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells.
Journal of neuroimmunology 2006;181(1-2):13-8.
2006: Gisela Grecksch; Katharina Bartzsch; Antje Widera; Axel Becker; Volker Höllt; Thomas Koch
Development of tolerance and sensitization to different opioid agonists in rats.
Psychopharmacology 2006;186(2):177-84.
2006: Thomas Koch; Dai-Fei Wu; Li-Quan Yang; Lars-Ove Brandenburg; Volker Höllt
Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors.
Journal of neurochemistry 2006;97(2):365-72.
2006: Christine Börner; Volker Höllt; Jürgen Kraus
Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
Molecular pharmacology 2006;69(4):1486-91.
2006: Peter Mayer; Volker Höllt
Pharmacogenetics of opioid receptors and addiction.
Pharmacogenetics and genomics 2006;16(1):1-7.
2005: Susanne Ammon-Treiber; D Stolze; H Schröder; Horace H Loh; Volker Höllt
Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model.
Neuropharmacology 2005;49(8):1160-9.
2005: Susanne Ammon-Treiber; Volker Höllt
Morphine-induced changes of gene expression in the brain.
Addiction biology 2005;10(1):81-9.
2005: Susanne Meis; Ludmila Sosulina; Stefan Schulz; Volker Höllt; Hans-Christian Pape
Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala.
The European journal of neuroscience 2005;21(3):755-62.
2005: Peter Mayer; Volker Höllt
Genetic disposition to addictive disorders--current knowledge and future perspectives.
Current opinion in pharmacology 2005;5(1):4-8.
2005: Thomas Koch; Antje Widera; Katharina Bartzsch; Stefan Schulz; Lars-Ove Brandenburg; Nicole Wundrack; Andrea Beyer; Gisela Grecksch; Volker Höllt
Receptor endocytosis counteracts the development of opioid tolerance.
Molecular pharmacology 2005;67(1):280-7.
2004: Solveig Schulz; Christoph Röcken; Christian Mawrin; Wolfgang Weise; Volker Höllt; Stefan Schulz
Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8235-42.
2004: Ralf Stumm; Chun Zhou; Stefan Schulz; Matthias Endres; Golo Kronenberg; Jeremy P Allen; Giovanni Tulipano; Volker Höllt
Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(50):11404-15.
2004: Christine Börner; Michael Wöltje; Volker Höllt; Jürgen Kraus
STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.
Journal of neurochemistry 2004;91(6):1493-500.
2004: Christine Börner; Jürgen Kraus; Helmut Schröder; Hermann Ammer; Volker Höllt
Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6.
Molecular pharmacology 2004;66(6):1719-26.
2004: Stefan Schulz; Dana Mayer; Manuela Pfeiffer; Ralf Stumm; Thomas Koch; Volker Höllt
Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.
The EMBO journal 2004;23(16):3282-9.
2004: Susanne Ammon-Treiber; Helga Tischmeyer; Uta Riechert; Volker Höllt
Gene expression of transcription factors in the rat brain after morphine withdrawal.
Neurochemical research 2004;29(6):1267-73.
2004: Giovanni Tulipano; Ralf Stumm; Manuela Pfeiffer; Hans-Jürgen Kreienkamp; Volker Höllt; Stefan Schulz
Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.
The Journal of biological chemistry 2004;279(20):21374-82.
2004: Andrea Beyer; Thomas Koch; Helmut Schröder; Stefan Schulz; Volker Höllt
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
Journal of neurochemistry 2004;89(3):553-60.
2004: Gisela Grecksch; Axel Becker; Helmut Schroeder; Jürgen Kraus; Horace H Loh; Volker Höllt
Accelerated kindling development in mu-opioid receptor deficient mice.
Naunyn-Schmiedeberg's archives of pharmacology 2004;369(3):287-93.
2004: Thomas Koch; Lars-Ove Brandenburg; Yingjian Liang; Stefan Schulz; Andrea Beyer; Helmut Schröder; Volker Höllt
Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization.
Journal of neurochemistry 2004;88(3):680-8.
2004: Ralf Stumm; Chun Zhou; Stefan Schulz; Volker Höllt
Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation.
The Journal of comparative neurology 2004;469(1):107-18.
2004: Susanne Ammon-Treiber; Gisela Grecksch; Ralf Stumm; Uta Riechert; Helga Tischmeyer; Anke Reichenauer; Volker Höllt
Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment.
Cell stress & chaperones 2004;9(2):182-97.
2004: Christian Mawrin; Stefan Schulz; Steffen U Pauli; Tim Treuheit; Sabine Diete; Knut Dietzmann; Raimund Firsching; Solveig Schulz; Volker Höllt
Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas.
Journal of neuropathology and experimental neurology 2004;63(1):13-9.
2003: Manuela Pfeiffer; Susanne Kirscht; Ralf Stumm; Thomas Koch; Daifei Wu; Magdalena Laugsch; Helmut Schröder; Volker Höllt; Stefan Schulz
Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization.
The Journal of biological chemistry 2003;278(51):51630-7.
2003: Jochen Mundschenk; Nicole Unger; Solveig Schulz; Volker Höllt; Stefan Schulz; Rainer Steinke; Hendrik Lehnert
Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.
The Journal of clinical endocrinology and metabolism 2003;88(11):5150-7.
2003: Jürgen Kraus; Christine Börner; Elisa Giannini; Volker Höllt
The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene.
Molecular pharmacology 2003;64(4):876-84.
2003: Peter Mayer; Thomas Kroslak; Helga Tischmeyer; Volker Höllt
A truncated delta opioid receptor, spontaneously produced in human but not rat neuroblastoma cells, interferes with signaling of the full-length receptor.
Neuroscience letters 2003;344(1):62-4.
2003: Ralf Stumm; Chun Zhou; Toshiaki Ara; Françoise Lazarini; Monique Dubois-Dalcq; Takashi Nagasawa; Volker Höllt; Stefan Schulz
CXCR4 regulates interneuron migration in the developing neocortex.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(12):5123-30.
2003: Susanne Ammon; Peter Mayer; Uta Riechert; Helga Tischmeyer; Volker Höllt
Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.
Brain research. Molecular brain research 2003;112(1-2):113-25.
2003: Jürgen Kraus; Christine Börner; Volker Höllt
Distinct palindromic extensions of the 5'-TTC...GAA-3' motif allow STAT6 binding in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(2):304-6.
2002: Peter Mayer; Susanne Ammon; Holger Braun; Helga Tischmeyer; Uta Riechert; Evelyn Kahl; Volker Höllt
Gene expression profile after intense second messenger activation in cortical primary neurones.
Journal of neurochemistry 2002;82(5):1077-86.
2002: Peter Mayer; M Erdtmann-Vourliotis; Uta Riechert; Susanne Ammon; Volker Höllt
Mild stress sensitizes the brain's response to morphine.
Brain research. Molecular brain research 2002;104(2):143-7.
2002: Holger Braun; Karina Schäfer; Volker Höllt
BetaIII tubulin-expressing neurons reveal enhanced neurogenesis in hippocampal and cortical structures after a contusion trauma in rats.
Journal of neurotrauma 2002;19(8):975-83.
2002: Ralf Stumm; Jutta Rummel; Vera Junker; Carsten Culmsee; Manuela Pfeiffer; Josef Krieglstein; Volker Höllt; Stefan Schulz
A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(14):5865-78.
2002: Manuela Pfeiffer; Thomas Koch; Helmut Schröder; Magdalena Laugsch; Volker Höllt; Stefan Schulz
Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.
The Journal of biological chemistry 2002;277(22):19762-72.
2002: Axel Becker; Gisela Grecksch; Jürgen Kraus; Horace H Loh; Helmut Schroeder; Volker Höllt
Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(4):296-302.
2002: Christine Börner; Volker Höllt; Jürgen Kraus
Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene.
Molecular pharmacology 2002;61(4):800-5.
2002: Holger Braun; Stefan Schulz; Volker Höllt
Expression changes of somatostatin receptor subtypes sst2A, sst2B, sst3 and sst4 after a cortical contusion trauma in rats.
Brain research 2002;930(1-2):191-9.
2002: Elisabeth Stögmann; Alexander Zimprich; Christoph Baumgartner; Susanne Aull-Watschinger; Volker Höllt; Fritz Zimprich
A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy.
Annals of neurology 2002;51(2):260-3.
2002: Volker Höllt
A polymorphism (A118G) in the mu-opioid receptor gene affects the response to morphine-6-glucuronide in humans.
Pharmacogenetics 2002;12(1):1-2.
2001: M Erdtmann-Vourliotis; Peter Mayer; Susanne Ammon; Uta Riechert; Volker Höllt
Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain.
Brain research. Molecular brain research 2001;95(1-2):129-37.
2001: Thomas Kroslak; Thomas Koch; Evelyn Kahl; Volker Höllt
Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling.
The Journal of biological chemistry 2001;276(43):39772-8.
2001: Peter Mayer; Volker Höllt
Allelic and somatic variations in the endogenous opioid system of humans.
Pharmacology & therapeutics 2001;91(3):167-77.
2001: Thomas Koch; Solveig Schulz; Manuela Pfeiffer; M Klutzny; Helmut Schröder; Evelyn Kahl; Volker Höllt
C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.
The Journal of biological chemistry 2001;276(33):31408-14.
2001: Axel Becker; Gisela Grecksch; Jürgen Kraus; Brigitte Peters; Helmut Schroeder; Solveig Schulz; Volker Höllt
Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(5):562-8.
2001: Manuela Pfeiffer; Thomas Koch; Helmut Schröder; M Klutzny; S Kirscht; Hans-Jürgen Kreienkamp; Volker Höllt; Solveig Schulz
Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).
The Journal of biological chemistry 2001;276(17):14027-36.
2000: I Brüggemann; Solveig Schulz; D Wiborny; Volker Höllt
Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions.
Brain research. Molecular brain research 2000;85(1-2):239-50.
2000: Peter Mayer; Helga Tischmeyer; M Jayasinghe; Bernd Bonnekoh; Harald Gollnick; H Teschemacher; Volker Höllt
A delta opioid receptor lacking the third cytoplasmic loop is generated by atypical mRNA processing in human malignomas.
FEBS letters 2000;480(2-3):156-60.
2000: Thomas Koch; Thomas Kroslak; M Averbeck; Peter Mayer; Helmut Schröder; E Raulf; Volker Höllt
Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling.
Molecular pharmacology 2000;58(2):328-34.
2000: Axel Becker; Gisela Grecksch; R Brödemann; Jürgen Kraus; Brigitte Peters; Helmut Schroeder; W Thiemann; Horace H Loh; Volker Höllt
Morphine self-administration in mu-opioid receptor-deficient mice.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(6):584-9.
2000: Axel Becker; Gisela Grecksch; W Thiemann; Volker Höllt
Pentylenetetrazol-kindling modulates stimulated dopamine release in the nucleus accumbens of rats.
Pharmacology, biochemistry, and behavior 2000;66(2):425-8.
2000: M Schreff; Solveig Schulz; M Händel; Gerburg Keilhoff; Holger Braun; G Pereira; M Klutzny; H Schmidt; Gerald Wolf; Volker Höllt
Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(10):3785-97.
2000: Solveig Schulz; M Händel; M Schreff; H Schmidt; Volker Höllt
Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies.
Journal of physiology, Paris 2000;94(3-4):259-64.
2000: Solveig Schulz; S U Pauli; S Schulz; M Händel; Knut Dietzmann; Raimund Firsching; Volker Höllt
Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1865-74.
2000: M Erdtmann-Vourliotis; Peter Mayer; Uta Riechert; Volker Höllt
Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum.
Brain research. Molecular brain research 2000;77(1):55-64.
2000: Henry Matthies; Helmut Schroeder; Axel Becker; Horace H Loh; Volker Höllt; Manfred Krug
Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioid receptor-deficient mice.
Neuropharmacology 2000;39(6):952-60.
2000: Michael Wöltje; Jürgen Kraus; Volker Höllt
Regulation of mouse delta-opioid receptor gene transcription: involvement of the transcription factors AP-1 and AP-2.
Journal of neurochemistry 2000;74(4):1355-62.
2000: A Zimprich; Jürgen Kraus; Michael Wöltje; Peter Mayer; E Rauch; Volker Höllt
An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression.
Journal of neurochemistry 2000;74(2):472-7.
2000: H Schmidt; Solveig Schulz; M Klutzny; Thomas Koch; M Händel; Volker Höllt
Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells.
Journal of neurochemistry 2000;74(1):414-22.
1999: Christine Rauca; K Schäfer; Volker Höllt
Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(6):633-8.
1999: Jürgen Kraus; Michael Wöltje; Volker Höllt
Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids.
FEBS letters 1999;459(2):200-4.
1999: M Erdtmann-Vourliotis; Peter Mayer; R Linke; Uta Riechert; Volker Höllt
Long-lasting sensitization towards morphine in motoric and limbic areas as determined by c-fos expression in rat brain.
Brain research. Molecular brain research 1999;72(1):1-16.
1999: M Erdtmann-Vourliotis; Peter Mayer; Uta Riechert; Volker Höllt
Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine).
Brain research. Molecular brain research 1999;71(2):313-24.
1999: Hans-Gert Bernstein; Gisela Grecksch; Axel Becker; Volker Höllt; Bernhard Bogerts
Cellular changes in rat brain areas associated with neonatal hippocampal damage.
Neuroreport 1999;10(11):2307-11.
1999: Gisela Grecksch; Axel Becker; Helmut Schroeder; Volker Höllt
Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(2):151-6.
1999: Solveig Schulz; H Siemer; Manfred Krug; Volker Höllt
Direct evidence for biphasic cAMP responsive element-binding protein phosphorylation during long-term potentiation in the rat dentate gyrus in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(13):5683-92.
1999: Axel Becker; Gisela Grecksch; Hans-Gert Bernstein; Volker Höllt; Bernhard Bogerts
Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis.
Psychopharmacology 1999;144(4):333-8.
1999: Gisela Grecksch; Hans-Gert Bernstein; Axel Becker; Volker Höllt; Bernhard Bogerts
Disruption of latent inhibition in rats with postnatal hippocampal lesions.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(6):525-32.
1999: M Erdtmann-Vourliotis; Peter Mayer; Uta Riechert; M Händel; J Kriebitzsch; Volker Höllt
Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization.
Brain research. Brain research protocols 1999;4(1):82-91.
1999: M Händel; Solveig Schulz; A Stanarius; M Schreff; M Erdtmann-Vourliotis; H Schmidt; Gerald Wolf; Volker Höllt
Selective targeting of somatostatin receptor 3 to neuronal cilia.
Neuroscience 1999;89(3):909-26.
1999: Ronald Wolf; Thomas Koch; Solveig Schulz; M Klutzny; Helmut Schröder; E Raulf; F Bühling; Volker Höllt
Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.
Molecular pharmacology 1999;55(2):263-8.
1998: Christine Rauca; Petra Henrich-Noack; K Schäfer; Volker Höllt; Klaus G Reymann
(S)-4C3HPG reduces infarct size after focal cerebral ischemia.
Neuropharmacology 1998;37(12):1649-52.
1998: Solveig Schulz; M Schreff; H Schmidt; M Händel; R Przewlocki; Volker Höllt
Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia.
The European journal of neuroscience 1998;10(12):3700-8.
1998: Solveig Schulz; H Schmidt; M Händel; M Schreff; Volker Höllt
Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord.
Neuroscience letters 1998;257(1):37-40.
1998: M Erdtmann-Vourliotis; Peter Mayer; Uta Riechert; Gisela Grecksch; Volker Höllt
Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats.
Brain research. Molecular brain research 1998;61(1-2):51-61.
1998: Solveig Schulz; S Schulz; Johannes Schmitt; D Wiborny; H Schmidt; S Olbricht; Wolfgang Weise; Albert Roessner; C Gramsch; Volker Höllt
Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2047-52.
1998: Holger Braun; Solveig Schulz; Axel Becker; Helmut Schröder; Volker Höllt
Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain.
Brain research 1998;803(1-2):54-60.
1998: Thomas Koch; Solveig Schulz; Helmut Schröder; Ronald Wolf; E Raulf; Volker Höllt
Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization.
The Journal of biological chemistry 1998;273(22):13652-7.
1998: M Erdtmann-Vourliotis; Uta Riechert; Peter Mayer; Gisela Grecksch; Volker Höllt
Pentylenetetrazole (PTZ)-induced c-fos expression in the hippocampus of kindled rats is suppressed by concomitant treatment with naloxone.
Brain research 1998;792(2):299-308.
1998: M Schreff; Solveig Schulz; D Wiborny; Volker Höllt
Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord.
Neuroreport 1998;9(6):1031-4.
1998: Solveig Schulz; Volker Höllt
Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo.
The European journal of neuroscience 1998;10(3):1196-201.
1998: Solveig Schulz; M Schreff; Thomas Koch; A Zimprich; C Gramsch; R Elde; Volker Höllt
Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system.
Neuroscience 1998;82(2):613-22.
1997: Henry Matthies; Solveig Schulz; W Thiemann; H Siemer; H Schmidt; Manfred Krug; Volker Höllt
Design of a multiple slice interface chamber and application for resolving the temporal pattern of CREB phosphorylation in hippocampal long-term potentiation.
Journal of neuroscience methods 1997;78(1-2):173-9.
1997: Henry Matthies; Axel Becker; H Schröeder; Jürgen Kraus; Volker Höllt; Manfred Krug
Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation.
Neuroreport 1997;8(16):3533-5.
1997: Thomas Koch; Thomas Kroslak; Peter Mayer; E Raulf; Volker Höllt
Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization.
Journal of neurochemistry 1997;69(4):1767-70.
1997: Peter Mayer; H Rochlitz; E Rauch; H Rommelspacher; H E Hasse; S Schmidt; Volker Höllt
Association between a delta opioid receptor gene polymorphism and heroin dependence in man.
Neuroreport 1997;8(11):2547-50.
1996: Solveig Schulz; M Schreff; D Nüss; C Gramsch; Volker Höllt
Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions.
Neuroreport 1996;7(18):3021-5.
1996: Peter Mayer; S Schulzeck; J Kraus; A Zimprich; Volker Höllt
Promoter region and alternatively spliced exons of the rat mu-opioid receptor gene.
Journal of neurochemistry 1996;66(6):2272-8.
1996: B Bacher; X Wang; S Schulz; Volker Höllt
Induction of proenkephalin gene expression in cultured bovine chromaffin cells is dependent on protein synthesis of AP-1 proteins.
Journal of neurochemistry 1996;66(6):2264-71.
1995: Henry Matthies; H Schröder; M Wagner; Volker Höllt; Manfred Krug
NMDA/R1-antisense oligonucleotide influences the early stage of long-term potentiation in the CA1-region of rat hippocampus.
Neuroscience letters 1995;202(1-2):113-6.
1995: A Zimprich; T Simon; Volker Höllt
Transfected rat mu opioid receptors (rMOR1 and rMOR1B) stimulate phospholipase C and Ca2+ mobilization.
Neuroreport 1995;7(1):54-6.
1995: J Kraus; G Horn; A Zimprich; T Simon; Peter Mayer; Volker Höllt
Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter.
Biochemical and biophysical research communications 1995;215(2):591-7.
1995: A Zimprich; T Simon; Volker Höllt
Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.
FEBS letters 1995;359(2-3):142-6.
1995: J Kraus; Volker Höllt
Identification of a cAMP-response element on the human proopiomelanocortin gene upstream promoter.
DNA and cell biology 1995;14(2):103-10.
1994: M Vanetti; B Ziólkowska; X Wang; G Horn; Volker Höllt
mRNA distribution of two isoforms of somatostatin receptor 2 (mSSTR2A and mSSTR2B) in mouse brain.
Brain research. Molecular brain research 1994;27(1):45-50.
1993: M Vanetti; G Vogt; Volker Höllt
The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization.
FEBS letters 1993;331(3):260-6.
1993: J Kraus; M Buchfelder; Volker Höllt
Regulatory elements of the human proopiomelanocortin gene promoter.
DNA and cell biology 1993;12(6):527-36.
1993: M Kouba; M Vanetti; X Wang; M Schäfer; Volker Höllt
Cloning of a novel putative G-protein-coupled receptor (NLR) which is expressed in neuronal and lymphatic tissue.
FEBS letters 1993;321(2-3):173-8.
1992: M Vanetti; M Kouba; X Wang; G Vogt; Volker Höllt
Cloning and expression of a novel mouse somatostatin receptor (SSTR2B).
FEBS letters 1992;311(3):290-4.
1992: Volker Höllt; M Kouba; M Dietel; G Vogt
Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.
Biochemical pharmacology 1992;43(12):2601-8.
1992: Volker Höllt; G Horn
Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat.
The Clinical investigator 1992;70(3-4):224-31.
1992: Volker Höllt
Precursors of opioid peptides and their gene regulation.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():50A-51A.
1992: S Reimer; D J Sirinathsinghji; K E Nikolorakis; Volker Höllt
Differential dopaminergic regulation of proenkephalin and prodynorphin mRNAs in the basal ganglia of rats.
Brain research. Molecular brain research 1992;12(1-3):259-66.
1990: C J Farin; N Kley; Volker Höllt
Mechanisms involved in the transcriptional activation of proenkephalin gene expression in bovine chromaffin cells.
The Journal of biological chemistry 1990;265(31):19116-21.
1990: M E Moneta; Volker Höllt
Perforant path kindling induces differential alterations in the mRNA levels coding for prodynorphin and proenkephalin in the rat hippocampus.
Neuroscience letters 1990;110(3):273-8.
1990: S Reimer; Volker Höllt
Morphine increases proenkephalin gene expression in the adrenal medulla by a central mechanism.
Progress in clinical and biological research 1990;328():215-8.
1989: Günter K Stalla; J Stalla; K von Werder; O A Müller; Rupert Gerzer; Volker Höllt; K H Jakobs
Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme.
Endocrinology 1989;125(2):699-706.
1988: M J Millan; A Członkowski; B Morris; C Stein; R Arendt; A Huber; Volker Höllt; A Herz
Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.
Pain 1988;35(3):299-312.
1988: B J Morris; S Reimer; Volker Höllt; A Herz
Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway.
Brain research 1988;464(1):15-22.
1988: R Przewłocki; I Haarmann; K Nikolarakis; A Herz; Volker Höllt
Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat.
Brain research 1988;464(1):37-41.
1988: B J Morris; Volker Höllt; A Herz
Opioid gene expression in rat striatum is modulated via opioid receptors: evidence from localized receptor inactivation.
Neuroscience letters 1988;89(1):80-4.
1988: B J Morris; K J Feasey; G ten Bruggencate; A Herz; Volker Höllt
Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3226-30.
1988: B J Morris; Volker Höllt; A Herz
Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
Neuroscience 1988;25(2):525-32.
1988: Günter K Stalla; J Stalla; M Huber; J P Loeffler; Volker Höllt; K von Werder; O A Müller
Ketoconazole inhibits corticotropic cell function in vitro.
Endocrinology 1988;122(2):618-23.
1987: B J Morris; M E Moneta; G ten Bruggencate; Volker Höllt
Levels of prodynorphin mRNA in rat dentate gyrus are decreased during hippocampal kindling.
Neuroscience letters 1987;80(3):298-302.
1986: Volker Höllt; R Przewłocki; I Haarmann; Osborne Almeida; N Kley; M J Millan; A Herz
Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary.
Neuroendocrinology 1986;43(3):277-82.
1981: M J Millan; R Przewłocki; M Jerlicz; C Gramsch; Volker Höllt; A Herz
Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia.
Brain research 1981;208(2):325-38.
1980: Volker Höllt; I Haarmann; K Bovermann; M Jerlicz; A Herz
Dynorphin-related immunoreactive peptides in rat brain and pituitary.
Neuroscience letters 1980;18(2):149-53.
1980: Volker Höllt; I Haarmann; R Przewlocki; M Jerlicz
Long-term treatment of rats with morphine decreases in vitro biosynthesis in and release of beta-endorphin from intermediate/posterior lobes of pituitary.
Advances in biochemical psychopharmacology 1980;22():399-407.